Patient In Genzyme Drug Suit Says Class Claims Should Stay
A patient suffering from Gaucher disease who filed a proposed class action accusing drugmaker Genzyme Corp. of replacing his biweekly injection treatments with an ineffective drug that advanced his condition urged...To view the full article, register now.
Already a subscriber? Click here to view full article